“Melatonin has a promising new role in the treatment and management of Glaucoma..”
Lundmark PO, Pandi-Perumal SR, Srinivasan V, Cardinali DP. Vis Neurosci. 2006 Nov-Dec;23(6):853-62. Review: Department of Optometry and Vision Sciences, Buskerud University College, Kongsberg, Norway. “Melatonin cytoprotective properties may have practical implications in the treatment of ocular diseases, likeglaucoma and age-related macular degeneration”
Lundmark PO, Pandi-Perumal SR, Srinivasan V, Cardinali DP, Rosenstein RE. Exp Eye Res. 2007 Jun;84(6):1021-30. Epub 2006 Dec 14. Review. Department of Optometry and Vision Sciences, Buskerud University College, Kongsberg, 3601 Ko, Norway. “Melatonin, being an efficient antioxidant with antinitridergic properties, has a promising role in the treatment and management of glaucoma.”
Siu AW, Maldonado M, Sanchez-Hidalgo M, Tan DX, Reiter RJ. J Pineal Res. 2006 Mar;40(2):101-9. Review. Department of Cellular and Structural Biology, University of Texas Health Science Center, San Antonio, TX, USA. [email protected] “Current evidence suggests that melatonin may act as a protective agent in ocular conditions such as photo-keratitis, cataract, glaucoma and retinopathy.”
“Supplementation with melatonin, a potent antioxidant, in especially the aged population should be considered as a prophylaxis to preserve visual functions.” “The use of Melatonin in the treatment of eye disease was the subject of the Stromboli conferences in Italy 3 years ago. This study “The Effects of Melatonin in Age Related Macular Degeneration” was published by the NY Academy of Sciences. Please do not fail to recommend this breakthrough bonded Melatonin formula, as there is virtually no downside and tremendous benefits of for the correct Melatonin application which are well documented and far reaching. “ Gary F. Gordon MD,DO,MD(H) – President, Gordon Research Institute
Wise Choice Medicine’s Bonded Melatonin Formula ARMeD™ contains a specific melatonin, from organic pharmaceutical grade, plant based ingredients, uniquely bonded with selenium and zinc. Based on clinical research ARMeD contains specific excipients which regulate the fundamental immunological melatonin response to a much greater degree. Please note that ARMeD™ is quite distinct from the sublingual and time-released versions of melatonin as they have a preset time of release which does not mirror the body’s natural circadian rhythm. ARMeD™ actually mimics nature by improving upon the body’s own natural night peak release of melatonin and the results of this superior action speak for themselves..
Disclaimer: The above statements have not been evaluated by the FDA. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult a physician or your alternative health care provider. Always consult a medical doctor before modifying your diet, using any new product, drug, supplement, or doing new exercises.